Current status of reduced-intensity allogeneic stem cell transplantation using alternative donors
نویسندگان
چکیده
منابع مشابه
Nonmyeloablative allogeneic stem cell transplantation using alternative donors.
BACKGROUND The reduced intensity of nonmyeloablative stem cell transplant (NMSCT) has enabled older patients to benefit from allogeneic therapy. Identification of suitable donors remains an obstacle. The use of alternative donors for stem cell therapy is essential to ensure broad applicability of allogeneic therapy. METHODS Clinical results using alternative hematopoietic stem cell donors are...
متن کاملSTEM CELL TRANSPLANTATION Current update on reduced intensity regimens for allogeneic stem cell transplantation
Beside chemotherapy, immunotherapy represents an approach based on the more or less specific recognition of tumoral cells. Allogeneic stem cell transplantation (ASCT) has been used now for more than 3 decades in the treatment of malignant hemopathies. Several lines of evidence could show that donorderived immuno-competent effectors can exert a potent long lasting graft-versus-tumor activity. To...
متن کاملCurrent status of reduced-intensity-conditioning allogeneic stem cell transplantation for acute myeloid leukemia.
Allogeneic stem cell transplantation (allo-SCT) is the most efficient antileukemic treatment for acute myeloblastic leukemia (AML). However, elderly patients can rarely benefit from standard myeloablative allo-SCT because of an unacceptable rate of procedure-related toxicities. This point is critical when considering AML patients in first complete remission. The development of the so-called red...
متن کاملReduced-intensity conditioning allogeneic stem cell transplantation in malignant lymphoma: current status
Allogeneic stem cell transplantation (allo-SCT) is a potential cure for patients with malignant lymphoma that is based on the graft-versus-lymphoma (GVL) effect. Myeloablative conditioning allo-SCT is associated with high mortality and morbidity, particularly in patients older than 45 years, heavily pretreated patients (prior hematopoietic stem cell transplantation or more than two lines of con...
متن کاملUse of alternative donors for allogeneic stem cell transplantation.
For patients without a human leukocyte antigen (HLA)-matched sibling or unrelated donor, options include transplantation from HLA-mismatched related donors, HLA-mismatched unrelated donors, or unrelated cord blood units. Graft failure remains a problem in 10%-20% of cord blood transplants that contain a limited number of hematopoietic cells. Many approaches are tested in clinical trials to offs...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Leukemia
سال: 2007
ISSN: 0887-6924,1476-5551
DOI: 10.1038/sj.leu.2404932